Found 5 matching trials
Intraperitoneal Injection of Oncolytic Viruses H101 for Patients With Refractory Malignant Ascites
PHASE2Assessment of effectiveness, safety and local immune activation of Oncolyti...
Location
Fudan University Shanghai Cancer Center
Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological Malignancies
PHASE2The purpose of this clinical trial is to evaluate the effectiveness and saf...
Location
The First Affiliated Hospital of Xi'an Jiao Tong University
Oncolytic Virotherapy Combined With Tislelizumab Plus Lenvatinib in Patients With Advanced Biliary Tract Cancer (OPTIONS-05)
PHASE2The objective of this study is to evaluate the efficacy and safety of oncol...
Location
Fudan University Shanghai Cancer Center
Oncorine (H101) Combined With Tislelizumab and Chemotherapy in Previously Untreated Advanced Non-small Cell Lung Cancer
PHASE1This is a single-arm, single-centre phase II study to evaluate the efficacy...
Location
Fujian Cancer Hospital
Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma
PHASE1The objective of this study is to evaluate the safety/tolerability efficacy...
Location
Fudan University Shanghai Cancer Center